共查询到20条相似文献,搜索用时 31 毫秒
1.
In patients with chronic coronary artery disease different therapeutic strategies, such as optimal medical therapy, revascularization by percutaneous coronary intervention or coronary artery bypass grafting have been shown to improve the prognosis and symptoms and yield proven superiority over other treatment strategies in different patient populations. Thus, individual assessment of cardiac function and structure is of paramount importance to choose the optimal therapeutic strategy and subsequently improve patient prognosis. In this setting cardiac magnetic resonance imaging (CMR) has been shown to provide important diagnostic information. Myocardial ischemia can be detected by either perfusion stress CMR demonstrating perfusion deficits indicative of hemodynamically relevant coronary artery stenosis or dobutamin stress CMR for objectifying wall motion abnormalities during stress. Both techniques are superior to single photon emission computerized tomography and stress echocardiography in specific patient populations. Myocardial viability can be assessed by means of end-diastolic wall thickness or delayed enhancement imaging which allows quantification of the transmural extent of scarring. Furthermore, low-dose dobutamin stress CMR can detect a contractile reserve. Delayed enhancement imaging leads to accurate results due to its high resolution, can be performed at rest requiring no stress within a short time period and is easy to analyze. Thus this technique can be recommended as the favored technique to assess myocardial viability. In the following article the CMR techniques for ischemia and viability testing will be presented and their role in diagnosis and therapy of chronic myocardial ischemia will be discussed. 相似文献
2.
MRI for the diagnosis of myocardial ischemia and viability 总被引:2,自引:0,他引:2
Assessment of myocardial ischemia and viability plays a crucial role in the clinical management of patients with coronary artery disease. Recently, cardiovascular MRI has emerged as an important noninvasive diagnostic modality in the assessment of coronary artery disease. MRI is able to evaluate both myocardial perfusion as well as myocardial contractile reserve. Because of its superior spatial resolution, integration of qualitative and quantitative methodology, and excellent reproducibility, MRI has advantages over conventional noninvasive modalities currently used in the evaluation of myocardial ischemia and viability, and may well emerge as the premier noninvasive technique in the assessment of patients with coronary artery disease. The authors review the rapidly expanding recent literature that has now established cardiovascular MRI (including dobutamine cine MRI and vasodilator perfusion MRI techniques) as an ideal choice in the evaluation of myocardial ischemia and delayed contrast-enhanced MRI and low-dose dobutamine cine MRI for evaluation of viability. Comparisons with more established techniques such as dobutamine stress echocardiography, single photon emission computed tomography perfusion imaging, and positron emission tomography are reviewed. 相似文献
3.
Ian Paterson Lisa M. Mielniczuk Eileen O'Meara Aaron So James A. White 《The Canadian journal of cardiology》2013
A variety of cardiac imaging tests are used to help manage patients with heart failure (HF). This article reviews current and future HF applications for the major noninvasive imaging modalities: transthoracic echocardiography (TTE), single-photon emission computed tomography (SPECT), positron emission tomography (PET), cardiovascular magnetic resonance (CMR), and computed tomography (CT). TTE is the primary imaging test used in the evaluation of patients with HF, given its widespread availability and reliability in assessing cardiac structure and function. Recent developments in myocardial strain, 3-dimensional TTE, and echo contrast appear to offer superior diagnostic and prognostic information. SPECT imaging is a common method employed to detect ischemia and viability in patients with HF; however, PET offers higher diagnostic accuracy for both. Ongoing study of sympathetic and molecular imaging techniques may enable early disease detection, better risk stratification, and ultimately targeted treatment interventions. CMR provides high-quality information on cardiac structure and function and allows the characterization of myocardial tissue. Myocardial late gadolinium enhancement allows the determination of HF etiology and may predict patient outcomes and treatment response. Cardiac CT has become a reliable means for detecting coronary artery disease, and recent advances have enabled concurrent myocardial function, perfusion, and scar analyses. Overall, available imaging methods provide reliable measures of cardiac performance in HF, and recent advances will allow detection of subclinical disease. More data are needed demonstrating the specific clinical value of imaging methods and particularly subclinical disease detection in large-scale, clinical settings. 相似文献
4.
Opinion statement Cardiac magnetic resonance (CMR) has emerged as a versatile noninvasive tool for the comprehensive evaluation of patients
with suspected or established coronary artery disease (CAD). In a single imaging session, CMR can assess left ventricular
anatomy and function, myocardial perfusion, viability, and coronary luminal stenosis. Using specific pulse sequences, left
ventricular global and regional function can be assessed by cine CMR at rest and in response to inotropic stress; first-pass
perfusion quantified by vasodilator stress; myocardial viability evaluated by delayed enhancement imaging and also by functional
reserve; and coronary artery stenosis assessed by angiography. All these modalities can be achieved with high spatial resolution
and image contrast, without exposure to ionizing radiation, and within a reasonable time frame of about 1 hour of scan time.
Also, the imaging planes can be programmed to provide identical views of the heart for each type of image, thereby facilitating
intermodality comparisons. There is early but accumulating evidence that the accuracy and prognostic values of many of these
modalities are comparable or superior to radionuclide scintigraphy and echocardiography in head-to-head studies. Current limitations
unique to CMR include the inability to perform exercise stress testing inside the CMR suite and exclusion of patients with
indwelling metallic devices such as defibrillators and pacemakers. Despite these limitations, CMR is unique in its multifaceted
approach that can be specifically tailored to the clinical question at hand, making it arguably the best tool for the diagnosis
and management of CAD. With the rapid pace of advancement in CMR hardware and pulse sequence technologies, the clinical use
of this powerful technique is likely to grow even greater in this area. 相似文献
5.
Juerg Schwitter 《Journal of nuclear cardiology》2006,13(6):841-854
Cardiovascular magnetic resonance (CMR) has been shown to provide high quality data on cardiac and valvular function, perfusion, viability, blood flow, and potentially, on cardiac metabolism as well. Several of these CMR applications (eg, function and viability assessment) matured during the past years and are now established components of a cardiac workup. Perfusion-CMR is close to this status and is already a major contributor to cardiac examinations in a growing number of expert centers. Large multicenter perfusion-CMR trials comparing the diagnostic performance of CMR with other techniques were recently reported yielding areas under the receiver-operator-characteristics curve as a high as 0.85 for coronary artery disease detection (MR-IMPACT). Anticipating a growing role for perfusion-CMR in cardiology in the near future, this article discusses the principles of perfusion-CMR and its integration into the workup of patient with coronary artery disease (CAD). In addition to a functional study, this integration is mainly composed of a perfusion-CMR part, followed by a viability assessment by late enhancement CMR techniques. The principal characteristics of these CMR techniques are compared with those of single photon emission computed tomography (SPECT) and positron emission tomography (PET). After introduction into principles and techniques of perfusion-CMR, some open questions in perfusion-CMR and challenges for the future are addressed. Finally, newer CMR applications are shortly mentioned utilizing hyperpolarized carbon-13 compounds in experimental models for quantification of myocardial perfusion and for real-time assessment of metabolic pathways in postischemic myocardium. 相似文献
6.
Mitchell JH Hadden TB Wilson JM Achari A Muthupillai R Flamm SD 《The American journal of cardiology》2007,100(2):296-301
In Takotsubo cardiomyopathy, or transient left ventricular (LV) apical ballooning syndrome, normalization of wall motion can occur after as long as 3 months. We report 1 of the largest series to date outside Japan and emphasize the utility of cardiac magnetic resonance imaging (CMR) to show a lack of irreversible damage in the acute setting, thereby reliably predicting recovery. During the previous 6 years, we saw 22 patients who met the following criteria: (1) a suspected myocardial infarction based on symptoms, an abnormal electrocardiogram, and/or elevated serum cardiac markers; (2) an anteroapical wall motion abnormality; and (3) no significant occlusive epicardial coronary artery disease or observed vasospasm. Ten patients underwent delayed enhancement CMR to assess myocardial viability during the index presentation. All 10 patients had an absence of irreversible damage, as evidenced by lack of gadolinium "hyperenhancement"; later, their LV function returned to normal. Eight other patients, available for outpatient follow-up evaluation, also had normalization of LV function. Takotsubo cardiomyopathy is increasingly being recognized outside Japan and must be distinguished from acute myocardial infarction. In conclusion, CMR is useful to document segmental LV dysfunction and lack of irreversible damage and to predict functional recovery. 相似文献
7.
Firschke C 《Herz》1998,23(8):483-490
The most benefit from the evaluation of myocardial viability in coronary artery disease is expected in patients with reduced left ventricular function. There is increasing evidence that the outcome of this patient group is better after revascularization if viable myocardium was present before as compared to patients without pre-reperfusion myocardial viability. Therefore, diagnostic tools for the detection of viable myocardium are of enormous therapeutic and economic relevance. The contrast echocardiographic demonstration of myocardial microvascular integrity has been demonstrated to be a corollary of myocellular viability in the experimental and clinical setting. In animal models of reperfusion in acute myocardial infarction, it could be demonstrated that myocardial echocontrast defects, however, only accurately estimate the extent of microvascular damage and the amount of viable tissue after reactive hyperemia has abated. In patients, immediately after reperfusion of the infarct-related artery in acute myocardial infarction, myocardial areas of no reflow could be detected using contrast echocardiography. It has been shown that these myocardial segments exhibit significantly reduced recovery of regional contractile function weeks after reperfusion. In contrast, regions with myocardial microvascular integrity as defined by contrast echocardiography recover function to a significantly higher degree. Furthermore, in patients with remote myocardial infarction, myocardial opacification by contrast echocardiography indicates myocardial collateral perfusion with preserved tissue viability and a high probability of functional recovery after reperfusion. In patients with chronic coronary artery disease and reduced left ventricular ejection fraction, functional recovery could be predicted by myocardial contrast echocardiography with a very high sensitivity in several studies. The lower specificity of the technique may be due to the fact that recovery of contractile function after reperfusion may not be expected in all segments at rest (which was used as the gold standard for viability evaluation in these studies) but rather during physical or pharmacological stress. Therefore, post-reperfusion demonstration of contractile reserve might be a more adequate criterion for the assessment of diagnostic accuracy of myocardial contrast echocardiography for pre-reperfusion viability detection. So far, for the evaluation of myocardial viability, myocardial contrast echocardiography has been exclusively performed using intracoronary injection of echo contrast media; based on the evidence from various studies, this technique is ready for routine clinical application; the place of venous myocardial contrast echocardiography for this purpose, which is an extremely promising technique, however, remains to be defined. 相似文献
8.
PURPOSE OF REVIEW: Myocardial contrast echocardiography is a recently developed technique that permits the noninvasive assessment of myocardial perfusion. Myocardial contrast enhancement from microbubbles characteristically reflects the myocardial blood volume. The analysis of microbubble kinetics using quantitative myocardial contrast echocardiography permits the evaluation of myocardial blood flow both at rest and during pharmacological stress. RECENT FINDINGS: Myocardial contrast echocardiography has been shown to have good concordance with single photon emission computed tomography for the localization of perfusion abnormalities. As a result of its better spatial resolution and the fact that it tracks myocardial blood flow changes, it seems to have higher sensitivity for the detection of angiographically significant coronary artery disease, while maintaining similar specificity to single photon emission computed tomography. Low mechanical index imaging techniques (real-time myocardial contrast echocardiography) have the advantage of permitting simultaneous analysis of wall motion and perfusion, which is particularly important during dobutamine stress. Myocardial perfusion analysis using real-time myocardial contrast echocardiography has been shown to have higher sensitivity and diagnostic accuracy than wall motion analysis for the detection of coronary artery disease. Quantitative myocardial contrast echocardiography seems to overcome the expertise requirements for appropriate interpretation of myocardial perfusion images, and may have been demonstrated to be an accurate supplemental technique for estimating the severity of coronary artery disease. SUMMARY: Recent technological advances have positioned myocardial contrast echocardiography as a safe and feasible technique for the evaluation of myocardial perfusion. The analysis of myocardial perfusion using myocardial contrast echocardiography has higher diagnostic accuracy than wall motion analysis for detecting coronary artery disease. 相似文献
9.
Plein S Greenwood JP Ridgway JP Cranny G Ball SG Sivananthan MU 《Journal of the American College of Cardiology》2004,44(11):2173-2181
OBJECTIVES: The goal of this study was to determine: 1) if the presence of significant coronary stenosis in patients presenting with non-ST-segment elevation acute coronary syndromes (NSTE-ACS) can be predicted by cardiac magnetic resonance (CMR) imaging; and 2) if the analysis of several CMR methods improves its diagnostic yield compared with analysis of individual methods. BACKGROUND: With modern acquisition techniques, several CMR methods for the assessment of coronary artery disease (CAD) can be combined in a single noninvasive scanning session. Such a multicomponent CMR examination has not previously been applied to a large patient population, in particular those with a high prevalence of CAD in an acute situation. METHODS: Sixty-eight patients presenting with NSTE-ACS underwent CMR imaging of myocardial function, perfusion (rest and adenosine-stress), viability (by late contrast enhancement), and coronary artery anatomy. Visual analysis of CMR was carried out. First, all CMR data were reviewed in combination ("comprehensive analysis"). In further separate analyses, each CMR method was analyzed individually. The ability of CMR to detect coronary stenosis >/=70% on X-ray angiography was determined. RESULTS: Comprehensive CMR analysis yielded a sensitivity of 96% and a specificity of 83% to predict the presence of significant coronary stenosis and was more accurate than analysis of any individual CMR method; CMR was significantly more sensitive and accurate than the Thrombolysis In Myocardial Infarction risk score (p < 0.001). CONCLUSIONS: Cardiac magnetic resonance imaging accurately predicts the presence of significant CAD in patients with NSTE-ACS. In this study, a comprehensive analysis of several CMR methods improved the accuracy of the test. 相似文献
10.
Considerable technical advances over the past decade have increased the clinical application of cardiovascular magnetic resonance (CMR) imaging. A comprehensive CMR examination can accurately measure left and right ventricular size and function, identify the presence and extent of reversible versus irreversible myocardial injury, and detect inducible ischemia. Streamlined protocols allow such a CMR examination to be a time-efficient diagnostic tool in patients with coronary artery disease. Moreover, edema imaging with T2-weighted CMR allows the detection of acute coronary syndromes. In this review, we present the relevant CMR methods and discuss practical uses of CMR in acute and chronic ischemic heart disease. 相似文献
11.
Cardiovascular magnetic resonance (CMR) is an evolving technology with growing indications within the clinical cardiology setting. This review article summarises the current clinical applications of CMR. The focus is on the use of CMR in the diagnosis of coronary artery disease with summaries of validation literature in CMR viability, myocardial perfusion, and dobutamine CMR. Practical uses of CMR in non-coronary diseases are also discussed. 相似文献
12.
Detecting viable myocardium, whether hibernating or stunned, is of clinical significance in patients with coronary artery disease and left ventricular dysfunction. Echocardiographic assessments of myocardial thickening and endocardial excursion during dobutamine infusion provide a highly specific marker for myocardial viability, but with relatively less sensitivity. The additional modalities of myocardial contrast echocardiography and tissue Doppler have recently been proposed to provide further, quantitative measures of myocardial viability assessment. Cardiac magnetic resonance (CMR) has become popular for the assessment of myocardial viability as it can assess cardiac function, volumes, myocardial scar, and perfusion with high-spatial resolution. Both 'delayed enhancement' CMR and dobutamine stress CMR have important roles in the assessment of patients with ischaemic cardiomyopathy. This article reviews the recent advances in both echocardiography and CMR for the clinical assessment of myocardial viability. It attempts to provide a pragmatic approach toward the patient-specific assessment of this important clinical problem. 相似文献
13.
Nuno Bettencourt Amedeo Chiribiri Andreas Schuster Eike Nagel 《Current heart failure reports》2009,6(3):142-153
In the past decade, cardiac magnetic resonance (CMR) has evolved dramatically. Its clinical applications are now a major tool
in the diagnosis and prognostic assessment of patients with ischemic heart disease. CMR can be used for detection and quantification
of ischemia and for viability assessment using different techniques that are now well validated. Scar can be easily detected
using contrast enhancement (late gadolinium enhancement). Ischemia detection is usually achieved with stress CMR techniques,
whereas prediction for the recovery of function (detection of dysfunctional but viable myocardial segments) can be deduced
from scar and stress imaging. Although determination of which approach is better may depend on the population group, the major
advantage of CMR is the ability to integrate different information about anatomy, wall motion, myocardial perfusion, and tissue
characterization in a single comprehensive examination. 相似文献
14.
Robert Soufer MD Holley M. Dey MD Chin K. Ng PhD Barry L. Zaret MD 《The American journal of cardiology》1995,75(17):1220-1223
Technetium-99m methoxyisobutyl isonitrile (technetium-99m sestamibi [MIBI]) is distributed in the myocardium according to blood flow. Reports comparing stress rest sestamibi protocols with reinfection thallium or resting fluorodeoxyglucose (FDG), or both, in patients with coronary artery disease have shown appreciable discordance regarding myocardial viability in these settings. We performed this analysis with regard to regional comparisons within discordant segments and made comparisons in a subset of patients who underwent revascularization. Thirty-seven patients with coronary artery disease had single-photon emission computed tomography MIBI, N-13 ammonia/18FDG positron emission tomography (PET), and radionuclide ventriculography performed at rest. One hundred two segments were viable and 29 were nonviable by both MIBI and FDG. The concordance was 71%. In MIBI nonviable/ FDG viable segments, most of the discordance was in the inferior wall. In MIBI nonviable discordant segments, FDG accurately predicted an increase in percent regional ejection fraction (preoperative 36% [± 5 SE] to postoperative 48% [± 5.5 SE] [p < 0.0006]). MIBI underestimates myocardial viability as assessed by PET. Seventy-one percent of myocardial segments were concordant by both quantitative sestamibi single-photon emission computed tomography and FDG PET. Discordance in MIBI nonviable segments was predominantly in the inferior wall. PET can be helpful in detecting myocardial viability in patients suspected of having had MIBI nonviability in the inferior wall. 相似文献
15.
To appreciate the impact that key developments will have on the future of cardiovascular magnetic resonance (CMR) imaging,
it is instructive to consider its present status. CMR has passed the threshold of being used primarily by innovators, and
is now in the early adopter stage. To reach this threshold has taken many years, but its adoption by early majority users
is expected to accelerate the growth of CMR. A number of factors govern its natural growth potential, including physician
education and credentialing, scanner availability, technology, and reimbursement policies. The intrinsic dimensional accuracy
of CMR, coupled with its high level of reproducibility, make it ideal for inclusion in trials, potentially with dramatic reductions
in trial duration and the number of subjects required. Clinically, there are a number of applications for which CMR is widely
regarded as being the diagnostic test of choice. Software and hardware developments that speed up the basic CMR procedure
are being incorporated into scanners, extending the functionality of routine applications such as flow imaging and tag visualization.
Exciting areas that are close to routine application include coronary artery imaging, and evaluation of myocardial perfusion
and viability status. 相似文献
16.
Magnetic resonance imaging (MRI) is gaining importance in cardiology as the noninvasive test of choice for patients with a
multitude of cardiovascular problems. Recently, cardiovascular MRI has emerged as an important noninvasive diagnostic modality
in the assessment of coronary artery disease. Because of its superior spatial resolution, integration of qualitative and quantitative
methodology, and excellent reproducibility, MRI has advantages over conventional noninvasive modalities currently used in
the evaluation of coronary artery disease. This article reviews the rapidly expanding recent literature that has now established
cardiovascular MRI as an ideal choice in the evaluation of myocardial ischemia (including dobutamine cine MRI and vasodilator
perfusion MRI techniques). We further discuss the role of delayed contrast-enhanced MRI and low-dose dobutamine cine MRI for
evaluation of myocardial viability. Comparisons with more established techniques, such as dobutamine stress echocardiography,
single-photon emission computed tomography perfusion imaging, and positron emission tomography, are reviewed. 相似文献
17.
In the past decade, cardiovascular magnetic resonance (CMR) has evolved considerably. Its clinical applications enable the diagnosis and prognostic assessment of patients with ischemic heart disease. CMR is safe, with absence of any ionizing radiation, and offers the greatest information from a single test, allowing the assessment of myocardial morphology, myocardial function and viability. Stress-CMR can be used for detection and quantification of ischemia. This article analyses the technical approach, the limits and reviews the available literature about diagnostic performance of stress CMR testing and its results in the prognostication of cardiac patients. With further improvements in CMR techniques and the establishment of a standardized study protocol, stress-CMR will play a pivotal role in managing patients with ischemic heart disease. 相似文献
18.
Adrian S H Cheng Tammy J Pegg Theodoros D Karamitsos Nick Searle Michael Jerosch-Herold Robin P Choudhury Adrian P Banning Stefan Neubauer Matthew D Robson Joseph B Selvanayagam 《Journal of the American College of Cardiology》2007,49(25):2440-2449
OBJECTIVES: This study was designed to establish the diagnostic accuracy of cardiovascular magnetic resonance (CMR) perfusion imaging at 3-Tesla (T) in suspected coronary artery disease (CAD). BACKGROUND: Myocardial perfusion imaging is considered one of the most compelling applications for CMR at 3-T. The 3-T systems provide increased signal-to-noise ratio and contrast enhancement (compared with 1.5-T), which can potentially improve spatial resolution and image quality. METHODS: Sixty-one patients (age 64 +/- 8 years) referred for elective diagnostic coronary angiography (CA) for investigation of exertional chest pain were studied (before angiogram) with first-pass perfusion CMR at both 1.5- and 3-T and at stress (140 microg/kg/min intravenous adenosine, Adenoscan, Sanofi-Synthelabo, Guildford, United Kingdom) and rest. Four short-axis images were acquired during every heartbeat using a saturation recovery fast-gradient echo sequence and 0.04 mmol/kg Gd-DTPA bolus injection. Quantitative CA served as the reference standard. Perfusion deficits were interpreted visually by 2 blinded observers. We defined CAD angiographically as the presence of > or =1 stenosis of > or =50% diameter in any of the main epicardial coronary arteries or their branches with a diameter of > or =2 mm. RESULTS: The prevalence of CAD was 66%. All perfusion images were found to be visually interpretable for diagnosis. We found that 3-T CMR perfusion imaging provided a higher diagnostic accuracy (90% vs. 82%), sensitivity (98% vs. 90%), specificity (76% vs. 67%), positive predictive value (89% vs. 84%), and negative predictive value (94% vs. 78%) for detection of significant coronary stenoses compared with 1.5-T. The diagnostic performance of 3-T perfusion imaging was significantly greater than that of 1.5-T in identifying both single-vessel disease (area under receiver-operator characteristic [ROC] curve: 0.89 +/- 0.05 vs. 0.70 +/- 0.08; p < 0.05) and multivessel disease (area under ROC curve: 0.95 +/- 0.03 vs. 0.82 +/- 0.06; p < 0.05). There was no difference between field strengths for the overall detection of coronary disease (area under ROC curve: 0.87 +/- 0.05 vs. 0.78 +/- 0.06; p = 0.23). CONCLUSIONS: Our study showed that 3-T CMR perfusion imaging is superior to 1.5-T for prediction of significant single- and multi-vessel coronary disease, and 3-T may become the preferred CMR field strength for myocardial perfusion assessment in clinical practice. 相似文献
19.
Cardiovascular magnetic resonance (CMR) imaging has evolved rapidly and is now accepted as a powerful diagnostic tool with significant clinical and research applications. Clinical 3 Tesla (3 T) scanners are increasingly available and offer improved diagnostic capabilities compared to 1.5 T scanners for perfusion, viability, and coronary imaging. Although technical challenges remain for cardiac imaging at higher field strengths such as balanced steady state free precession (bSSFP) cine imaging, the majority of cardiac applications are feasible at 3 T with comparable or superior image quality to that of 1.5 T. This review will focus on the benefits and limitations of 3 T CMR for common clinical applications and examine areas in development for potential clinical use. 相似文献
20.
近年来随着人们对冠状动脉疾病的深入研究,冠状动脉微血管疾病的临床意义日益受到人们的重视,许多现有的证据表明冠状动脉微血管疾病是心脏疾病的病因之一,在冠状动脉疾病的发展中起着重要的作用。心脏磁共振技术具有多序列、多层次、高分辨率的特点,可以一站式地评价心脏的结构、运动及心肌的活性,被广泛运用于心血管疾病的诊疗过程中。现就心脏磁共振技术在冠状动脉微血管疾病中的运用进行综述。 相似文献